JCT  Vol.6 No.15 , December 2015
Evidence for Placental HPV Infection in Both HIV Positive and Negative Women
ABSTRACT
Human papillomaviruses (HPVs) have previously been reported to infect epithelial trophoblast cells of the placenta. To investigate this possibility, 200 placental samples from Zambian women were separated into HIV+ and HIV- groups and tested for HPV by redundant primer PCR, using GP5+/GP6+ and CPI/CPII primer sets. Three HPV genotypes (HPV6, 16 and 90) were detected in placental samples. Whereas, 20 different HPV genotypes were detected in vaginal sampling of the same patients, suggesting that compartment specific sub-populations of HPV may exist. The incidence of HPV16 in placental samples was almost 2-fold greater in HIV+ women compared to HIV- (p = 0.0241). HPV16 L1 expression, detected by immunochemistry, was significantly higher in HIV+ than HIV- samples (p = 0.0231). HPV16 DNA was detected in the nuclei of trophoblast cells by in situ hybridization. Overall, these results suggest that HPVs infect the placenta and that HIV significantly influences these infections.

Cite this paper
Chisanga, C. , Eggert, D. , Mitchell, C. , Wood, C. and Angeletti, P. (2015) Evidence for Placental HPV Infection in Both HIV Positive and Negative Women. Journal of Cancer Therapy, 6, 1276-1289. doi: 10.4236/jct.2015.615140.
References
[1]   Stanley, M. (2010) Pathology and Epidemiology of HPV Infection in Females. Gynecologic Oncology, 117, S5-S10.
http://dx.doi.org/10.1016/j.ygyno.2010.04.001

[2]   Bernard, H.U., Burk, R.D., Chen, Z., van Doorslaer, K., zur Hausen, H. and de Villiers, E.M. (2010) Classification of Papillomaviruses (PVs) Based on 189 PV Types and Proposal of Taxonomic Amendments. Virology, 401, 70-79.
http://dx.doi.org/10.1016/j.virol.2010.02.002

[3]   Stanley, M.A. (2012) Epithelial Cell Responses to Infection with Human Papillomavirus. Clinical Microbiology Reviews, 25, 215-222.
http://dx.doi.org/10.1128/CMR.05028-11

[4]   Kajitani, N., Satsuka, A., Kawate, A. and Sakai, H. (2012) Productive Lifecycle of Human Papillomaviruses That Depends upon Squamous Epithelial Differentiation. Frontiers in Microbiology, 3, 152.
http://dx.doi.org/10.3389/fmicb.2012.00152

[5]   Spoden, G., Freitag, K., Husmann, M., Boller, K., Sapp, M., Lambert, C. and Florin, L. (2008) Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16—Involvement of Tetraspanin-Enriched Microdomains (TEMs). PLoS One, 3, 0003313.
http://dx.doi.org/10.1371/journal.pone.0003313

[6]   Rombaldi, R.L., Serafini, E.P., Mandelli, J., Zimmermann, E. and Losquiavo, K.P. (2008) Transplacental Transmission of Human Papillomavirus. Virology Journal, 5, 5-106.
http://dx.doi.org/10.1186/1743-422X-5-106

[7]   Lee, S.M., Park, J.S., Norwitz, E.R., Koo, J.N., Oh, I.H., Park, J.W., Kim, S.M., Kim, Y.H., Park, C.W. and Song, Y.S. (2013) Risk of Vertical Transmission of Human Papillomavirus throughout Pregnancy: A Prospective Study. PLoS One, 8, e66368.
http://dx.doi.org/10.1371/journal.pone.0066368

[8]   Weyn, C., Thomas, D., Jani, J., Guizani, M., Donner, C., Van Rysselberge, M., Hans, C., Bossens, M., Englert, Y. and Fontaine, V. (2011) Evidence of Human Papillomavirus in the Placenta. Journal of Infectious Disease, 203, 341-343.
http://dx.doi.org/10.1093/infdis/jiq056

[9]   Uribarren-Berrueta, O., Sainchez-Corona, J., Montoya-Fuentes, H.C., Trujillo-Hernaindez, B. and Vaisquez, C. (2012) Presence of HPV DNA in Placenta and Cervix of Pregnant Mexican Women. Archives of Gynecology and Obstetrics, 285, 55-60.
http://dx.doi.org/10.1007/s00404-011-1911-0

[10]   Sarkola, M.E., Grenman, S.E., Rintala, M.A., Syrjanen, K.J. and Syrjanen, S.M. (2008) Human Papillomavirus in the Placenta and Umbilical Cord Blood. Acta Obstetricia et Gynecologica Scandinavica, 87, 1181-1188.
http://dx.doi.org/10.1080/00016340802468308

[11]   Liu, Y., You, H. and Hermonat, P.L. (2005) Studying the HPV Life Cycle in 3A Trophoblasts and Resulting Pathophysiology. Methods in Molecular Medicine, 119, 237-245.

[12]   You, H., Liu, Y., Agrawal, N., Prasad, C.K., Chiriva-Internati, M., Lowery, C.L., Kay, H.H. and Hermonat, P.L. (2003) Infection, Replication, and Cytopathology of Human Papillomavirus Type 31 in Trophoblasts. Virology, 316, 281-289.
http://dx.doi.org/10.1016/j.virol.2003.08.020

[13]   Liu, Y., You, H., Chiriva-Internati, M., Korourian, S., Lowery, C.L., Carey, M.J., Smith, C.V. and Hermonat, P.L. (2001) Display of Complete Life Cycle of Human Papillomavirus Type 16 in Cultured Placental Trophoblasts. Virology, 290, 99-105.
http://dx.doi.org/10.1006/viro.2001.1135

[14]   You, H., Liu, Y., Carey, M.J., Lowery, C.L. and Hermonat, P.L. (2002) Defective 3A Trophoblast-Endometrial Cell Adhesion and Altered 3A Growth and Survival by Human Papillomavirus Type 16 Oncogenes. Molecular Cancer Research, 1, 25-31.

[15]   Dolei, A., Curreli, S., Marongiu, P., Pierangeli, A., Gomes, E., Bucci, M., Serra, C. and Degener, A.M. (1999) Human Immunodeficiency Virus Infection in Vitro Activates Naturally Integrated Human Papillomavirus Type 18 and Induces Synthesis of the L1 Capsid Protein. Journal of General Virology, 80, 2937-2944.
http://dx.doi.org/10.1099/0022-1317-80-11-2937

[16]   Heard, I., Tassie, J.M., Schmitz, V., Mandelbrot, L., Kazatchkine, M.D. and Orth, G. (2000) Increased Risk of Cervical Disease among Human Immunodeficiency Virus-Infected Women with Severe Immunosuppression and High Human Papillomavirus Load. Obstetrics & Gynecology, 96, 403-409.
http://dx.doi.org/10.1016/S0029-7844(00)00948-0

[17]   Palefsky, J. (2006) Biology of HPV in HIV infection. Advances in Dental Research, 19, 99-105.
http://dx.doi.org/10.1177/154407370601900120

[18]   Sun, X.W., Ellerbrock, T.V., Lungu, O., Chiasson, M.A., Bush, T.J. and Wright Jr., T.C. (1995) Human Papillomavirus Infection in Human Immunodeficiency Virus-Seropositive Women. Obstetrics & Gynecology, 85, 680-686.
http://dx.doi.org/10.1016/0029-7844(95)00025-M

[19]   Ahdieh, L., Klein, R.S., Burk, R., Cu-Uvin, S., Schuman, P., Duerr, A., Safaeian, M., Astemborski, J., Daniel, R. and Shah, K. (2001) Prevalence, Incidence, and Type-Specific Persistence of Human Papillomavirus in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Women. Journal of Infectious Diseases, 184, 682-690.
http://dx.doi.org/10.1086/323081

[20]   Critchlow, C.W., Holmes, K.K., Wood, R., Krueger, L., Dunphy, C., Vernon, D.A., Daling, J.R. and Kiviat, N.B. (1992) Association of Human Immunodeficiency Virus and Anal Human Papillomavirus Infection among Homosexual Men. Archives of Internal Medicine, 152, 1673-1676.
http://dx.doi.org/10.1001/archinte.1992.00400200105019

[21]   Scott, M., Nakagawa, M. and Moscicki, A.-B. (2001) Cell-Mediated Immune Response to Human Papillomavirus Infection. Clinical and Diagnostic Laboratory Immunology, 8, 209-220.

[22]   Stanley, M. (2006) Immune Responses to Human Papillomavirus. Vaccine, 30, S16-S22.
http://dx.doi.org/10.1016/j.vaccine.2005.09.002

[23]   Fruchter, R.G., Maiman, M., Sedlis, A., Bartley, L., Camilien, L. and Arrastia, C.D. (1996) Multiple Recurrences of Cervical Intraepithelial Neoplasia in Women with the Human Immunodeficiency Virus. Obstetrics & Gynecology, 87, 338-344.
http://dx.doi.org/10.1016/0029-7844(95)00408-4

[24]   Ng’andwe, C., Lowe, J., Richards, P., Hause, L., Wood, C. and Angeletti, P. (2007) The Distribution of Sexually-Transmitted Human Papillomaviruses in HIV Positive and Negative Patients in Zambia, Africa. BMC Infectious Diseases, 7, 77.
http://dx.doi.org/10.1186/1471-2334-7-77

[25]   Pikor, L.A., Enfield, K.S., Cameron, H. and Lam, W.L. (2011) DNA Extraction from Paraffin Embedded Material for Genetic and Epigenetic Analyses. Journal of Visualized Experiments, 26, e2763.
http://dx.doi.org/10.3791/2763

[26]   Mao, T.L., Kurman, R.J., Jeng, Y.M., Huang, W. and Shih Ie, M. (2008) HSD3B1 as a Novel Trophoblast-Associated Marker That Assists in the Differential Diagnosis of Trophoblastic Tumors and Tumorlike Lesions. The American Journal of Surgical Pathology, 32, 236-242.
http://dx.doi.org/10.1097/PAS.0b013e31812e0046

[27]   Wang, Z., Christensen, N., Schiller, J.T. and Dillner, J. (1997) A Monoclonal Antibody against Intact Human Papillomavirus Type 16 Capsids Blocks the Serological Reactivity of Most Human Sera. Journal of General Virology, 78, 2209-2215.
http://dx.doi.org/10.1099/0022-1317-78-9-2209

[28]   Sahasrabuddhe, V.V., Mwanahamuntu, M.H., Vermund, S.H., Huh, W.K., Lyon, M.D., Stringer, J.S. and Parham, G.P. (2007) Prevalence and Distribution of HPV Genotypes among HIV-Infected Women in Zambia. British Journal of Cancer, 96, 1480-1483.
http://dx.doi.org/10.1038/sj.bjc.6603737

[29]   Sarkola, M.E., GréNman, S.E., Rintala, M.A.M., SyrjANen, K.J. and SyrjANen, S.M. (2008) Human Papillomavirus in the Placenta and Umbilical Cord Blood. Acta Obstetricia et Gynecologica Scandinavica, 87, 1181-1188.
http://dx.doi.org/10.1080/00016340802468308

[30]   Weyn, C., Thomas, D., Jani, J., Guizani, M., Donner, C.R., Van Rysselberge, M., Hans, C., Bossens, M., Englert, Y. and Fontaine, V.R. (2011) Evidence of Human Papillomavirus in the Placenta. Journal of Infectious Diseases, 203, 341-343.
http://dx.doi.org/10.1093/infdis/jiq056

[31]   Evander, M., Frazer, I.H., Payne, E., Qi, Y.M., Hengst, K. and McMillan, N.A. (1997) Identification of the Alpha6 Integrin as a Candidate Receptor for Papillomaviruses. Journal of Virology, 71, 2449-2456.

[32]   Kirnbauer, R., Booy, F., Cheng, N., Lowy, D.R. and Schiller, J.T. (1992) Papillomavirus L1 Major Capsid Protein Self-Assembles into Virus-Like Particles That Are Highly Immunogenic. Proceedings of the National Academy of Sciences of the United States of America, 89, 12180-12184.
http://dx.doi.org/10.1073/pnas.89.24.12180

[33]   Roden, R.B., Armstrong, A., Haderer, P., Christensen, N.D., Hubbert, N.L., Lowy, D.R., Schiller, J.T. and Kirnbauer, R. (1997) Characterization of a Human Papillomavirus Type 16 Variant-Dependent Neutralizing Epitope. Journal of Virology, 71, 6247-6252.

[34]   Ng’andwe, C., Lowe, J.J., Richards, P.J., Hause, L., Wood, C. and Angeletti, P.C. (2007) The Distribution of Sexually-Transmitted Human Papillomaviruses in HIV Positive and Negative Patients in Zambia, Africa. BMC Infectious Diseases, 7, 77.
http://dx.doi.org/10.1186/1471-2334-7-77

[35]   Quiroga-Garza, G., Zhou, H., Mody, D.R., Schwartz, M.R. and Ge, Y. (2013) Unexpected High Prevalence of HPV 90 Infection in an Underserved Population: Is It Really a Low-Risk Genotype? Archives of Pathology & Laboratory Medicine, 137, 1569-1573.
http://dx.doi.org/10.5858/arpa.2012-0640-OA

[36]   Tornesello, M.L., Buonaguro, F.M., Beth-Giraldo, E. and Giraldo, G. (1993) Human Immunodeficiency Virus Type 1 Tat Gene Enhances Human Papillomavirus Early Gene Expression. Intervirology, 36, 57-64.

[37]   You, H., Liu, Y., Agrawal, N., Prasad, C.K., Edwards, J.L., Osborne, A.F., Korourian, S., Lowery, C.L. and Hermonat, P.L. (2008) Multiple Human Papillomavirus Types Replicate in 3A Trophoblasts. Placenta, 29, 30-38.
http://dx.doi.org/10.1016/j.placenta.2007.08.005

[38]   Elfgren, K., Bistoletti, P., Dillner, L., Walboomers, J.M., Meijer, C.J. and Dillner, J. (1996) Conization for Cervical Intraepithelial Neoplasia Is Followed by Disappearance of Human Papillomavirus Deoxyribonucleic Acid and a Decline in Serum and Cervical Mucus Antibodies against Human Papillomavirus Antigens. American Journal of Obstetrics & Gynecology, 174, 937-942.
http://dx.doi.org/10.1016/S0002-9378(96)70330-7

[39]   zur Hausen, H. (1991) Viruses in Human Cancers. Science, 254, 1167-1173.
http://dx.doi.org/10.1126/science.1659743

[40]   Hammer, A. (2011) Immunological Regulation of Trophoblast Invasion. Journal of Reproductive Immunology, 90, 21-28.
http://dx.doi.org/10.1016/j.jri.2011.05.001

[41]   Redman, C.W. and Sargent, I.L. (2010) Immunology of Pre-Eclampsia. American Journal of Reproductive Immunology, 63, 534-543.
http://dx.doi.org/10.1111/j.1600-0897.2010.00831.x

 
 
Top